[
    "yl}pyrimidine-2,4-diamine. Prepared according to general procedure 9 from 4-chloro-6-(2,3- dimethylphenyl)pyrimidin-2-amine and N'-(3-pyridyl)ethane-1 ,2-diamine. LCMS [M+H]<sup>+</sup> 335; <sup>1</sup> H NMR (400 MHz, CD<sub>3</sub>OD) \u03b4<sub>\u0397</sub> ppm 8.10 - 8.12 (m, 1 H), 7.97 - 8.00 (m, 1 H), 7.72 - 7.80 (m, 2 H), 7.34 - 7.38 (m, 1 H), 7.22 - 7.27 (m, 1 H), 7.19 (dd, J=1.0, 0.5 Hz, 1 H), 6.04 (s, 1 H), 3.75 - 3.80 (m, 2 H), 3.54 (t, J=6.2 Hz, 2 H), 2.36 (s, 3 H), 2.25 (s, 3 H). \n\n</p></p> xampe xampe \n\n</p></p> Exampl Example 56 \n\n </p> Exam Example 57 \n\n </p> Example 53 Example 58 \n\n </p> Exam le 54 Example 59 \n\n </p> Example 55 Example 60 \n\n\n\n \n\n \n\n </p> Example 71 Example 76 \n\n </p> Example 72 Example \n\n </p> Exampl Exampl \n\n </p> Example Exampl \n\n </p> Example 75 Example 80 \n\n</p></p>Example 131 Example 136 \n\n </p> Example 132 Example 137 \n\n </p>Exa Example 138 \n\n </p> Exa Exampl \n\n </p> Example 135 Example 140 \n\n\n\n \n\n</p></p></p></p></p></p> Exam Example 246 \n\n </p> Example 242 Example 247 \n\n </p> Example 243 Example 248 \n\n </p> Example 244 Example 249 \n\n </p> Example 245 Example 250 \n\n\n\n \n\n\n\n \n\n</p></p>\n ple 316 </p>\n E l 315 E l 320 \n\n</p></p> NH<sub>2</sub></p>Ex Example 336 \n\n </p>Exam le 337 </p></p> Exa Example 338 \n\n </p>E Example 339 </p></p> Example 335 Example 340 \n\n\n\n \n\n</p>\n Example 369 </p>\n ample 379 </p></p>\n xample 408 mple 409\n\n \n\n\n\n \n\n\n\n E l 425 E l 430 \n\n\n\n \n\n\n\n \n\n</p></p>Biological Examples </p>Biological Example 1 </p> MTH1 enzymatic assay and IC50 value determination </p> MTH1 catalyzes the hydrolysis of dGTP to dGMP and PPi. By coupling the reaction to pyrophosphatase added in excess PPi is converted to Pi that can be \n\n detected by using the malachite green assay reagent. Briefly, for IC<sub>50</sub> value determination the compound to be analyzed is diluted in assay buffer in a 1 :3 dilution series generating 12 different compound concentrations giving a final DMSO concentration of 1 % in the assay well. MTH1 diluted in assay buffer (100 mM Tris-acetate, 40 mM NaCI, 10 mM magnesium acetate, 1 mM DTT and</p>0.005% Tween 20) fortified with E.coli pyrophosphatase (0.8 U/ml) is added to a final concentration of 4.8 nM. dGTP diluted in assay buffer is added to a final concentration of 100 \u03bc\u039c. The reaction mixture is incubated with shaking for 15 minutes at 22\u00b0C. To 100 \u03bc\u0399 reaction mixture is 25 \u03bc\u0399 Malachite green assay regent (0.095% Malachite green in 17% H<sub>2</sub>S0<sub>4</sub>, 1.5% Ammonium molybdate, 0.17% Tween 20) added followed by incubation with shaking for 15 minutes at 22\u00b0C. The absorbance of the assay plate is read at 630 nm using an EnVision Multilabel plate reader. The IC<sub>50</sub> value is determined by fitting a dose response curve to the data points using nonlinear regression analysis and the equation Y=Bottom + (Top-Bottom)/(1 +10<sup>A</sup>((LoglC<sub>5</sub>o-X)*HillSlope)), where Y is the read absorbance at 630 nm and X is log[compound]. </p>Using this approach the following representati"
]